Response Biomedical Inks C$2M Debt Financing Pact | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical today announced that it has entered into a C$2 million (US$1.9 million) debt financing agreement with Orbimed Advisors.

The Vancouver, British Columbia-based firm has structured the debt agreement so it can borrow money in tranches. Upon execution of the pact, it will draw down C$275,000 from Orbimed. It also has an option to draw down up to three further tranches of C$575,000, for a maximum potential draw of C$2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.